The Medicover Story
Founded in Europe, grown in India — Medicover’s Indian hospital network pairs a Nasdaq Stockholm-listed group’s standards with south and west India’s clinical talent.
Medicover was founded as an international healthcare and diagnostic-services organisation, developing an integrated model across preventive medicine, specialist care, diagnostics, fertility and wellness in Europe.
Medicover listed on Nasdaq Stockholm, and in August acquired a majority stake in MaxCure Hospitals — the foundation of today’s Medicover Hospitals network in India.
Dedicated centres for cancer care and for women and child health created specialised environments for chemotherapy, cancer surgery, radiotherapy, maternity care, neonatal intensive care and paediatric treatment.
The network built 25+ cardiac catheterisation laboratories and 1,736+ ICU beds — supporting interventional cardiology, cardiac surgery, transplantation and complex critical care.
A major investment programme for new hospitals, super-speciality beds and technology upgrades across metropolitan and Tier-2 regions.
A 300-bed multi-speciality facility with 40+ specialised doctors opened in September 2025, expanding access from primary care to advanced treatment.
A 24-floor, 550-bed hospital opened in March 2026 with 18 operation theatres, robotic surgery, extensive ICU capacity — and the first 640-slice CT system in the Telugu states, alongside advanced MRI, PET-CT, CT-Linac and interventional imaging.


















































































